adtralza
L••• P••• A•••
Süreç
- Başvuru 2 Ocak 2019
- Bültende yayın Resmî Marka Bülteni 329 · 29 Temmuz 2019
- İtiraz penceresi (2 ay) Son gün 29 Eylül 2019 · kapandı
- Tescil Tescil no 2019 62688· Gazete 469 (29 Ocak 2021)
- Yenileme Koruma 10 yıl: yenileme tarihi Ocak 2029 (son 6 ay içinde başvurulur).
Resmî süreler ve işlemler için TÜRKPATENT esastır; Nomist bilgilendirme aracıdır.
Sınıflar ve kapsam
Mal ve hizmet listesi
Pharmaceutical and medical preparations for treatment of skin diseases, atopic dermatitis, autoimmune and inflammatory diseases and for treatment of the skin. Providing online forums for information and communication about skin diseases, atopic dermatitis, autoimmune and inflammatory diseases and in relation to treatment of the skin. Scientific and medical research in the field of skin diseases, atopic dermatitis, autoimmune and inflammatory diseases and in relation to treatment of the skin; research, development and scientific, medical research and pharmaceutical testing in the field of skin diseases, atopic dermatitis, autoimmune and inflammatory diseases and in relation to treatment of the skin; providing information and consulting services in the field of research, development and science in relation to skin diseases and treatment of the skin; pharmaceutical testing in the field of skin diseases, atopic dermatitis, autoimmune and inflammatory diseases and in relation to treatment of the skin. Medical services in the field of skin diseases, atopic dermatitis, autoimmune and inflammatory diseases and in relation to treatment of the skin; medical, health and pharmaceutical consultation services in the field of skin diseases, atopic dermatitis, autoimmune and inflammatory diseases and in relation to treatment of the skin; medical testing in the field of skin diseases, atopic dermatitis, autoimmune and inflammatory diseases and in relation to treatment of the skin.
Aynı bültende benzer başvurular
Bülten 329 içindeki 1.027 aynı-sınıf başvuru arasında Nomist'in benzerlik algoritmasına takılan yok.